Daacro   Report issue

For profit
Founded: Trier Germany (2006)

Organization Overview

First Clinical Trial
2017
NCT03353441
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Daacro

Active Ingredients

Drugs in Other Trials (5)

fish hydrolysate (1 trial)

glycine (1 trial)

hydroxytyrosol (1 trial)

lactobacillus casei (1 trial)

olive (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 4
  • # of Trial APIs: 5